Key facts
- NCIMB’s last known valuation is $10.2M (Apr 2025).
- It has raised $2.5M; the latest was Later Stage VC ($2.2M) in Apr 2025.
- Notable investors include Innovate UK, Maven Capital Partners UK, The Scottish National Investment Bank.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for NCIMB
- ·The full record, as it builds
Funding rounds
No funding rounds for NCIMB are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NCIMB
Developer of microbial technology designed to support life sciences, food and drink, energy, and environmental industries. The company's platform offers microbial identification, storage, and testing services, enabling clients to enhance process reliability and accelerate product development.
- Sector
- Healthcare
- HQ
- Aberdeen, United Kingdom
- Founded
- 1982
- Employees
- 30
- Website
- ncimb.com/
- Ownership
- Privately Held (backing)
NCIMB doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NCIMB shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NCIMB in its N-PORT filings yet. We sweep new filings monthly.